Indirect visualization of hematopoietic colony-forming stem cell (CFUs) as a possible target cell for Mycoplasma

Experientia
|April 15, 1987
PubMed

Insights

Researchers identified specific mycoplasma target cells in mice using antiserum. A portion of 7-day colony-forming units (CFUs) were inactivated, suggesting they are candidate target cells for Mycoplasma arthritidis (M. arthritidis) infection.

Area of Science:

  • Immunology
  • Microbiology
  • Hematology

Background:

  • Mycoplasma arthritidis (M. arthritidis) is a pathogen known to cause various infections.
  • Understanding the host-pathogen interaction is crucial for developing effective treatments.
  • Colony-forming units (CFUs) in bone marrow represent a population of cells involved in immune responses and hematopoiesis.

Purpose of the Study:

  • To identify potential target cells of M. arthritidis within the bone marrow.
  • To investigate the susceptibility of different CFU populations to immune inactivation.

Main Methods:

  • CBA mice were infected with live M. arthritidis organisms.
  • Bone marrow was collected 1 day post-infection.
  • Specific rabbit antiserum against M. arthritidis was used in conjunction with complement to treat marrow cell populations.
  • The viability of 7-day and 11-day CFUs was assessed after treatment.

Main Results:

  • A portion of the 7-day CFU population in the bone marrow was inactivated by antiserum and complement treatment.
  • This inactivation suggests that these 7-day CFUs are susceptible to immune-mediated clearance.
  • The 11-day CFU population remained unaffected by the same treatment.

Conclusions:

  • The 7-day CFU population in CBA mice infected with M. arthritidis contains candidate target cells for the pathogen.
  • These findings provide insights into the cellular targets of M. arthritidis in the bone marrow.
  • Further research is warranted to elucidate the precise nature and role of these target cells.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K